Dermatology

Dermatology

Development and initial psychometric evaluation of patient reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa
Kimball A, Sundarum M, Banderas B, Foley C, and Shields AL
Journal of Dermatological Treatment

Development and psychometric evaluation of the Self-Assessment of Psoriasis Symptoms (SAPS) – clinical trial and the SAPS – Real world patient reported outcomes
Amstrong AW, Banderas B, Foley C, Stokes J, Sundaram M, Shields AL
Journal of Dermatological Treatment

Agreement between patient and clinician ratings of disease severity in hidradenitis suppurativa, rheumatoid arthritis, and chronic plaque psoriasis
Foley C, Banderas B, Sen R, Yip C, Dickie G, Lamoureux R
Poster presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research. Glasgow, Scotland. 4-8 November 2017

Assessing atopic dermatitis symptoms in adolescents and adults: Development of a patient-reported symptom diary
Hall R, Gater A, Wells J, Chen L, Papacharalambous J, Cappelleri JC, Hsu M-A
Poster presentation at the American Academy of Dermatology Annual Meeting, 3-7 March 2017

Psychometric evaluation of the Hidradenitis Suppurativa Symptom Assessment (HSSA) and Hidradenitis Suppurativa Impact Assessment (HSIA) in patients with hidradenitis suppurativa
Kimball A, Banderas B, Taylor F, McDonald J, Skup M, Calimlim B
European Academy of Dermatology and Venereology

Impacts of glabellar facial lines – A patient perspective
Solish N, Bertucci V, Hall S, Banderas, B, Foley C, Turner-Bowker DM, Shields AL,  Chung C, Rubio RG, Carruthers J
Poster presented at the 75th Annual American Academy of Dermatology (AAD) meeting. Orlando, Florida, USA, 2017

Adherence to topical therapies in actinic keratosis: A literature review
Foley P, Stockfleth E, Peris K, Basset-Seguin N, Cerio R, Sanches JA, Guillen C, Farrington E, Lebwohl M
Journal of Dermatological Treatment, 1-8

Evaluating the clinical meaning of the Hidradenitis Suppurativa Clinical Response (HiSCR)
Kimball AB, Sundaram M, Sen R, Naijun C, Shields AL, Gu Y, Okun MM
Poster presented at the 74th Annual Meeting of the American Academy of Dermatology (AAD), Washington DC, USA

Network meta-analysis to evaluate the efficacy of ixekizumab in the treatment of moderate-to-severe psoriasis
Hartz S, Walzer S, Dutronc Y, Himatlal Kiri S, Schacht A, Dakin H.
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Vienna, Austria, 29th Oct-2nd Nov 2016

Psychometric evaluation of the Self-Assessment of Psoriasis Symptoms (SAPS)-Clinical Trial and the SAPS-Real World Patient-reported outcomes
Armstrong A, Banderas B, Sundaram M, Foley C, Ojo F, Shields AL.
Poster presented at the 5th Congress of the Psoriasis International Network (PSO 2016), Paris, France, July 7th-9th, 2016

Content development of patient-reported outcome instruments for the measurement of the primary signs and symptoms chronic plaque psoriasis
Armstrong A, Sundaram M, Foley C, Pompilus F, Stokes J, Shields A.
Poster session presented at International Society for Quality of Life Research (ISOQOL), 22nd Annual Conference, Vancouver, Canada, 21-24 October 2015

Development of a patient-reported outcome instrument for the measurement of the sexual impacts of psoriasis
Cather JC, Horn EJ, Foley C, Sundaram M, Iovin R, Pompilus F,  Stokes J, AL Shields.
Presented at the 4th World Psoriasis & Psoriatic Arthritis Conference. Stockholm, Sweden, July 8-11 2015.

Development of a patient-reported outcome instrument for the measurement of the sexual impacts of psoriasis
Cather JC, Horn EJ, Foley C, Sundaram M, Iovin R, Pompilus F,  Stokes J, AL Shields.
Presented at the 73rd Annual Meeting of the American Academy of Dermatology. San Francisco, California, March 20-24, 2015

Development of a patient-reported outcomes instrument for the measurement of treatment satisfaction in plaque psoriasis
Armstrong A, Sundaram M, Foley C, Pompilus F, Stokes J, Shields AL.
Presented at the 4th World Psoriasis & Psoriatic Arthritis Conference. Stockholm, Sweden, July 8-11, 2015

Development of a patient-reported outcomes instrument for the measurement of treatment satisfaction in plaque psoriasis
Armstrong AW, Sundaram M, Foley C, Iovin R, Pompilus F, Stokes J, Shields AL.
Poster presented at the 23rd World Congress of Dermatology, Vancouver, Canada, 8-13 June 2015

Evaluating the dimensionality of complex PROs using bifactor analysis within an exploratory structural equation modeling framework: an example using the Patient-reported Scar Evaluation Questionnaire
Sen R, Pleil A, Coon C, Shields AL
Poster presented at the 22nd Annual Conference of International Society for Quality of Life Research (ISOQOL); Vancouver, Canada

Measuring disease specific impact and symptoms among patients with hidradenitis suppurativa
Kimball A, Sundaram M, Mathias A, Foley C, Shields A
Poster session presented at: 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Philadelphia, PA, USA, 16-20 May 2015

Development and validation of a novel patient-reported treatment satisfaction measure for hyperfunctional facial lines: facial line satisfaction questionnaire
Pompilus F, Burgess S, Hudgens S, Banderas B, Daniels S
J Cosmet Dermatol. 2015; doi: 10.1111/jocd.12166

In-depth investigation of patient-reported sexual, reproductive, and relationship impacts of psoriasis
Cather JC, Horn EJ, Sundaram M, Mukherjee Bal V, Wang K, Iovin R, Foley C, Pompilus F, Shields A
Poster session presented at: 72nd Annual Meeting of the American Academy of Dermatology, Denver, Colorado, USA, 21-25 March 2014

Patient adherence and non-persistence behaviour in real life actinic keratosis (AK) topical treatment in the UK, Germany and France
Erntoft S, Norlin J, Pollard C, Diepgen TL
Value in Health 2014, Volume 17, Issue 3, A287

Patient adherence and non-persistence behaviour in real life actinic keratosis (AK) topical treatment in the UK, Germany and France
Erntoft S, Norlin J, Pollard C, Diepgen TL
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 19th Annual International Congress, Montréal, Canada, 1-3 June 2014

Psychometric evaluation of a patient-reported treatment satisfaction measure for hyperfunctional facial lines in the upper face
Daniels S, Banderas B, Shields AL, Burgess S
Poster presented at the 72nd annual meeting of the American Academy of Dermatology. Denver, CO USA, 2014

Development of a new patient-reported outcome measure for facial acne: The Acne Symptom and Impact Scale (ASIS)
Alexis A, Daniels SR, Johnson N, Pompilus F, Burgess SM, Harper JC
J Drugs Dermatol 2014;13(3):333-340

The impact of upper facial lines and psychological impact of crow’s feet lines: Content validation of the Facial Line Outcomes (FLO-11) questionnaire
Yaworsky A, Daniels S, Tully S, Beddingfield F, Kowalski J, Fitzgerald K, Somogyi C, Burgess S
J Cosmet Dermatol 2014;13(4):297-306

In-depth Investigation of patient-reported sexual, reproductive, and relationship impacts of psoriasis
Cather JC, Horn EJ, Sundaram M, Mukherjee Bal V, Wang K, Iovin R, Foley C, Pompilus F, Shields A
Poster session presented at: 22nd Congress of the European Academy of Dermatology and Venereology, Istanbul, Turkey, October 2-6, 2013

In-depth Investigation of patient-reported sexual, reproductive, and relationship impacts of psoriasis
Cather JC, Horn EJ, Sundaram M, Mukherjee Bal V, Wang K, Foley C, Pompilus F, Shields A
Poster presented at the 22nd Annual European Academy of Dermatology and Venereology, Belgrade, Serbia, 2013

Is a picture worth a thousand words? The development of a clinician and patient reported photonumeric guide to assess scar severity
Pleil A, Jensen J, Galipeau N, Taylor F, Pompilus F, Shields AL
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 18th International Meeting, New Orleans, USA, 20 -22 May 2013

Patients’ experiences with hidradenitis suppurativa:  A qualitative study of symptoms and impacts
Kimball AB, Sundaram M, Mukherjee Bal V, Okun M
Poster session presented at: 71st Annual Meeting of the Amercian Academy of Dermatology, Miami, Florida, March 1-5, 2013

Psychometric performance of a new patient-reported psoriasis symptom diary
Nyirady J, Mallya UG, Guettner A, Papavassilis C, Strober BE, Gottlieb AB, Lebwohl M, Gwaltney CJ, Turner-Bowker DM, Shields AL
Value in Health,16(6), 1014-1022

Content assessment of the Facial Line Outcomes (FLO-11) questionnaire (MT)
Fitzgerald K, Yaworsky A, Daniels S, Galipeau N, Kornstein A, Evans C, Misra-Burgess S
Qual Life Res 2012;20:66

Do scars impact beyond just appearance? A report of the concept elicitation phase in the development of the patient reported scar evaluation questionnaire
Pleil A, Jensen J, Galipeau N, Taylor F, Pompilus F, Shields AL
Poster presented at the 15th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Berlin, Germany, 2012

Evaluating a measure of tanning abuse and dependence
Hillhouse J, Baker M, Turrisi R, Shields AL, Stapleton J, Jain S, Longacre I
Archives of Dermatology. 148(7):815-819

Development of an instrument mirroring patient and physician perception of psoriasis severity and treatment effect
De Climens R, Marant C, Arnould B, Thibout E
Poster presented at ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic

Content and psychometric validity of the Eyelash Satisfaction Questionnaire (ESQ) in China
Crawford B, Tanaka E, Zhu Y, Burgess S M
Value Health 2010;13:A542

Item reduction and psychometric validation of the Oily Skin Self-Assessment Scale (OSSAS) and the Oily Skin Impact Scale (OSIS)
Arbuckle R, Clark M, Harness J, Bonner N, Scott J, Draelos Z, Rizer R, Yeh Y, Copley-Merriman K
Value Health 2009;12:828

Psychometric validation of the Oily Skin Self-Assessment Scale (OSSAS) and the Oily Skin Impact Scale (OSIS)
Mamolo C, Harness J, Bonner N, Arbuckle R
JAAD 2009;60:P715